ANF and @AANEMorg Board Member John Morren, MD, recently spoke with NBC to share his insights on #ALS.
As a contributor to the Late-Onset Disease Consortium (LONDC), Dr. Morren is helping advance conversations around earlier recognition and improved patient care.
November is National Family Caregivers Month! We’re celebrating the dedication of those who help loved ones w/ neuromuscular diseases - managing appointments & providing comfort & tackling daily hurdles, caregivers are true heroes, making an impact every day! @AmNmFoundation
😀🎦Thanks to NBC News for having me highlight some benefits of cutting-edge AI neurotechnologies to a global audience today! #ClevelandClinic@AANEMorg@AANmember
NBC website: https://t.co/2FgZpKzNuB
Clip without ads: https://t.co/0o2hq72vUo
Honored giving the Reiner Plenary- "AI & the Future of EDX & NM Medicine" & the "Harnessing the Power of AI: Exploring AI Tools" sessions @AANEM Annual Meeting. Awesome engagement & AI interest conveyed throughout the meeting!👋 #AANEM#aaneminsavannah#NeuromuscularMedicine#EDX
📣 Finally in print! Check out our review with @jamorren about the novel MG therapeutics: https://t.co/1Ha1zeAGoo
Complement and FcRn inhibitors, B cell depletors, CAR-T cell therapy offer potentially better efficacy and safety compared to the conventional MG treatment options.
The Role of Artificial Intelligence in Electrodiagnostic and Neuromuscular Medicine: Current State and Future Directions | VuMedi https://t.co/vVuHtiZ3I2 via @vumedi@AANEMorg@MuscleAndNerve
In this paper, we looked at the predictors of disability and mortality in CRMP5-IgG paraneoplastic neurologic disorders. SCLC was the main determinant of mortality. @AKunchok@JRAbbatemarco@jamorren
Check out our recent publication:
https://t.co/39NvEALm6u
@CLENeurons